Marc Dunoyer
Chief Executive Officer at ALEXION PHARMACEUTICALS, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Pascal Soriot | M | 64 |
AstraZeneca UK Ltd.
 AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom.
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | 12 years |
| Charles Rowland | M | 65 |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 years |
| Nicolas Koebel | M | - |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 9 years |
| Ahmed Hamdy | M | 59 | 11 years | |
| André Choulika | M | 59 | 25 years | |
| David Sourdive | M | 57 | 25 years | |
| Simone Song | F | 59 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 7 years |
| Emma Walmsley | F | 55 | 14 years | |
| Phil Thomson | M | - | 13 years | |
| Jeffrey Pott | M | - | 29 years | |
| Joanne Beck | M | 63 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 years |
| Jon Ellis | M | 57 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 years |
| Tjeerd Barf | M | - |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | - |
| Michel Demaré | M | 67 | 5 years | |
| James Geraghty | M | 70 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 years |
| Alicia Secor | F | 62 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 years |
| Jonathan Thomas Charles Slade | M | 59 |
Astrazeneca Intermediate Holdings Ltd.
 Astrazeneca Intermediate Holdings Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Intermediate Holdings Ltd. operates as a British intermediate holding company through its subsidiaries and researches, manufactures, and markets pharmaceuticals. The private company is based in Cambridge, UK. | - |
| Andrea Spezzi | M | - |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 9 years |
| Aradhana Sarin | M | 50 | 3 years | |
| Shu Kam Mok | M | 63 | 5 years | |
| Gianluca Pirozzi | M | 47 | 5 years | |
| Rainer Boehm | M | 63 | 7 years | |
| Nazneen Rahman | M | - | 7 years | |
| Sean Christie | M | - | 3 years | |
| Pascal Claude Roland Soriot | - | - |
AstraZeneca UK Ltd.
AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom. | 12 years |
| Takafumi Horii | M | - |
AstraZeneca KK
 AstraZeneca KK Pharmaceuticals: MajorHealth Technology AstraZeneca KK develops, manufactures and sells prescription drugs. It also conducts medical research. The company was founded on April 11, 1975 and is headquartered in Osaka, Japan. | 2 years |
| Bobby Gaspar | M | 60 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 years |
| Mark Frattini | M | 58 | 4 years | |
| Sherilyn McCoy | F | 65 | 7 years | |
| Marie-Bleuenn Terrier | F | 42 | 16 years | |
| Axel-Sven Malkomes | M | 57 | 2 years | |
| Donald Bergstrom | M | 52 | 2 years | |
| Marcus Wallenberg | M | 68 | 25 years | |
| Pam Cheng | F | 53 | 9 years | |
| Laurent Arthaud | M | 61 | 13 years | |
| Adrian Charles Noel Kemp | M | 58 |
Astrazeneca Intermediate Holdings Ltd.
Astrazeneca Intermediate Holdings Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Intermediate Holdings Ltd. operates as a British intermediate holding company through its subsidiaries and researches, manufactures, and markets pharmaceuticals. The private company is based in Cambridge, UK. | 15 years |
| Roger Ulrich | M | - |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | 11 years |
| Pierre Bastid | M | 69 | 13 years | |
| Stephan Reynier | M | 55 | 13 years | |
| Deborah DiSanzo | F | 64 | 7 years | |
| Allard Kaptein | M | - |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | 12 years |
| Philip Broadley | M | 63 | 7 years | |
| Seng Cheng | M | - | 1 years | |
| Cécile Chartier | M | - | 1 years | |
| Regina Danielson | M | 60 | - | |
| Ruth Diazaraque | M | - | 1 years | |
| Pascalyne Wilson | M | - | - | |
| Christophe Hotermans | M | - | 4 years | |
| Jean-Pierre Garnier | M | 75 | 4 years | |
| Sarah Marshall | F | - | 10 years | |
| Frannie DeFranco | F | - | 14 years | |
| Josie Afolabi | F | - | 14 years | |
| Piyush Sharma | M | - | 7 years | |
| Kyung Nam-Wortman | F | 54 | 4 years | |
| Glen Frick | M | 57 | - | |
| Arthur Stril | M | 35 | 6 years | |
| Nicola Heffron | F | 52 | 1 years | |
| Morgan Sanford | F | - | - | |
| Tamar Thompson | F | 50 | 5 years | |
| Steve Doares | M | - | 4 years | |
| Iskra Reic | F | - | 23 years | |
| Helen MacPhee | F | 64 | - | |
| Frédéric Chéreau | M | 57 | 2 years | |
| Patryk Mikucki | M | 49 | - | |
| Philippe Duchateau | M | 61 | 23 years | |
| Ruud Dobber | M | - | 27 years | |
| María Cristina de Luna Basagoiti | F | - | 14 years | |
| Margareta Elisabeth Björk | M | 63 | 22 years | |
| Todd Spalding | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mark Rothera | M | 62 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 3 years |
| Simon Lowth | M | 62 | 6 years | |
| Leif Valdemar Johansson | M | 73 | 11 years | |
| Thomas Mount | M | - | 7 years | |
| Philippe Fauchet | M | 65 |
GlaxoSmithKline KK
 GlaxoSmithKline KK Household/Personal CareConsumer Non-Durables GlaxoSmithKline KK researches, develops, imports, manufactures and sells toiletry products. The company was founded on August 18, 1928 and is headquartered in Tokyo, Japan | 9 years |
| Jean-Philippe Courtois | M | 63 | 8 years | |
| Briggs Morrison | M | 65 | 3 years | |
| Ravi Rao | M | 55 | 7 years | |
| Jacques Dumas | M | 58 | 7 years | |
| Anjali Bansal | F | 53 | 6 years | |
| Ayesha Bharmal | F | - | 5 years | |
| Menelas Pangalos | M | 57 | 13 years | |
| Shriti Vadera | F | 62 | 7 years | |
| David Smith | M | - | 9 years | |
| Jing Ulrich | F | 56 | - | |
| Donald Bruce Burlington | M | 75 | 7 years | |
| Geneviéve B. Berger | M | 69 | 9 years | |
| Joseph Peter | M | 60 | - | |
| Judy Lewent | F | 75 | 10 years | |
| Nancy Rothwell | M | 68 | 9 years | |
| Lynn Elsenhans | F | 68 | 10 years | |
| Julian Heslop | M | 70 | 13 years | |
| Simon Dingemans | M | 61 | 8 years | |
| Graham Chipchase | M | 61 | 9 years | |
| John Varley | M | 67 | 9 years | |
| Stacey Cartwright | F | 60 | 5 years | |
| Rudolph Markham | M | 78 | 11 years | |
| Crispin Davis | M | 75 | 10 years | |
| James Murdoch | M | 51 | 3 years | |
| H. Culp | M | 60 | 9 years | |
| Michael Zinda | M | 53 | 16 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 64 | 64.00% |
| France | 17 | 17.00% |
| United States | 14 | 14.00% |
| Netherlands | 4 | 4.00% |
| Japan | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Marc Dunoyer
- Personal Network